Perioperative Nivolumab and Chemotherapy in Non-Small-Cell Lung Cancer. Reply

N Engl J Med. 2023 Oct 19;389(16):1534-1535. doi: 10.1056/NEJMc2310641.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Docetaxel / therapeutic use
  • Humans
  • Lung Neoplasms* / drug therapy
  • Nivolumab / therapeutic use

Substances

  • Nivolumab
  • Docetaxel